🔗 Share this article

A shadow economy for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, injection guides and assertions of rapid British shipping. Vendors market the substance there before redirecting customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and chemists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in users injecting products of unknown origin.

Several professionals said the popularity for the experimental drug could be connected to the increasing cost of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still breach medicines, advertising, and consumer regulations, risking fines, legal action or prison.

Platform Response and Content Removal

Based on TikTok, the platform has taken down violative material and prohibited associated hashtags and query recommendations. The company said it was committed to keeping the service safe and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to 9,000 members marketing retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of slimming results, positive testimonials and step-by-step instructions for preparing or administering at residence.

After moments of joining one group, a seller posted contact information, where most purchases occur. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, medical conditions or previous experience.

Product Details and Costs

Within these communities, posts show dark colored packages with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for Telegram said it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting substances they can’t verify. Although the science behind retatrutide is valid, these online products may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has previously seen patients harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose users to possibly significant health risks”.